CAL
FLGT icon

Capital Advisors Ltd’s Fulgent Genetics FLGT Stock Holding History

Capital Advisors Ltd’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4
Closed – – 1416
2024
Q4 		$0 Buy
+4
New +$78 ﹤0.01% 1444

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital Advisors Ltd's FLGT Position: Q1 2025 in Review

Capital Advisors Ltd sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 4 shares.

Capital Advisors Ltd first reported a position in FLGT in Q4 2024 and held it in 1 quarter. The position peaked at $0 in Q4 2024. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Capital Advisors Ltd reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • Capital Advisors Ltd sold 4 Fulgent Genetics shares in Q1 2025.
  • Capital Advisors Ltd first reported a position in Fulgent Genetics in Q4 2024 and held it in 1 quarter.
  • Capital Advisors Ltd's Fulgent Genetics position peaked at $0 in Q4 2024.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Capital Advisors Ltd's 13F filing for Q1 2025, filed 15 Apr 2025.